20/12/2018 |
Change of Director's Interest Notice - PH |
17/12/2018 |
Imugene Meets Endpoints in Phase 1b Gastric Cancer Immuno-oncology Trial |
21/11/2018 |
IMU Meets Endpoints in Phase 1b Gastric Cancer Trial |
21/11/2018 |
Change of Director's Interest Notice - LC |
21/11/2018 |
Appendix 3B and 708A Notice |
21/11/2018 |
Change of Director's Interest Notice - PH |
13/11/2018 |
Results of Meeting |
13/11/2018 |
AGM Presentation |
13/11/2018 |
Imugene Advances to Phase 2 in Gastric Cancer Immuno-oncology Trial |
09/11/2018 |
Imugene Received $1.85 million R&D Tax Incentive |
30/10/2018 |
Appendix 4C - quarterly |
22/10/2018 |
Change of Director's Interest Notice - AH |
22/10/2018 |
Appendix 3B (Exercise of Options) and 708A Notice |
09/10/2018 |
Notice of Annual General Meeting |
08/10/2018 |
Change in Executive Remuneration |
04/10/2018 |
European Society for Medical Oncology President joins Imugene Scientific Advisory Board |
01/10/2018 |
Imugene appoints leading cancer researcher to Scientific Advisory Board |
28/09/2018 |
Appendix 4G |
21/09/2018 |
Imugene commences cGMP manufacture of PD-1 cancer vaccine |
18/09/2018 |
Imugene appoints gastrointestinal cancer expert to Scientific Advisory Board |
11/09/2018 |
Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment |
31/08/2018 |
Appendix 4E and Audited Financial Report |
23/08/2018 |
Imugene appoints Dr Mark Marino Chief Medical Officer |
27/07/2018 |
2018 Bioshares Presentation |
23/07/2018 |
PD-1 cancer vaccine development update |
07/06/2018 |
Capital Raising Presentation |
07/06/2018 |
Prospectus |
07/06/2018 |
Imugene to Raise A$20.1 million |
07/06/2018 |
Imugene Licences Extensive B-Cell Immuno-Oncology Portfolio |
05/06/2018 |
Trading Halt |
28/03/2018 |
Leslie Chong Appointed as Managing Director |
18/02/2018 |
Imugene arginine modulator demonstrates activity in melanoma cancer model |
11/02/2018 |
Novel Anti-PD-1 Mimotope Vaccine Ready for Development |
09/02/2018 |
Imugene hosts investigator meeting for gastric cancer clinical trial |
07/02/2018 |
Cancer vaccine shows early promise in gastric cancer clinical trial |
29/01/2018 |
Business Update – December Quarter Appendix 4C |